← Back to search
THE INSTITUTE FOR CANCER RESEARCH
PHILADELPHIA, PA, 19111
UnclaimedClaim this profile (free)
Prime contracting experience
8 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER | 75N91019D00022USAspending | $1,237,620 | Jul 7, 2026 | May 18, 2022 – Nov 17, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIATED COLORECTAL CANCER IMMUNOPREVENTION | 75N91019D00022USAspending | $2,051,148 | May 12, 2026 | Jun 15, 2022 – May 14, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA | 75N91019D00022USAspending | $1,199,274 | Apr 7, 2026 | May 3, 2023 – May 2, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS | 75N91019D00022USAspending | $1,038,958 | Jan 29, 2026 | Jul 10, 2023 – Jul 9, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTION PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS | 75N91019D00022USAspending | $948,377 | Dec 11, 2025 | Sep 15, 2022 – Jun 14, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | TASK ORDER: PREVENTING LUNG CANCER BY TARGETING ACTIVATED STAT3 | 75N91019D00022USAspending | $779,932 | Feb 9, 2024 | Sep 21, 2020 – Mar 20, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) | HHSN261201500032IUSAspending | $884,185 | Jun 22, 2023 | Jul 25, 2018 – Jan 24, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) | HHSN261201500032IUSAspending | $988,252 | Jun 13, 2022 | Sep 20, 2016 – Jun 19, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.